Smiths Medical announced today that it launched its EchoGlo peripheral nerve block portfolio as part of the Portex pain management platform.
EchoGlo is a needle designed for echogenic brightness under ultrasound to enhance visualization and accuracy while delivering medication, helping to confidently place local anesthetic which could reduce post-operative dependency on opioids, according to a news release.
Minneapolis-based Smiths Medical touts its full EchoGlo portfolio launch as a way to offer clinicians more solutions through the Portex portfolio of pain management products.
“Smiths Medical is proud to offer EchoGlo nerve block needles as part of our patient to pump solution,” Smiths Medical senior director of global product management Jaimie Mattson said in the release. “Combining the echogenic brightness of EchoGlo products with our CADD pump portfolio provides a full solution for our clinicians and patients.”